Company Filing History:
Years Active: 2007
Title: The Innovative Contributions of Markus Neumann
Introduction
Markus Neumann is a notable inventor based in Lohof, Germany. He has made significant contributions to the field of biotechnology, particularly in the detection of HIV proteins. His work has implications for both research and clinical applications, showcasing the importance of innovation in addressing global health challenges.
Latest Patents
Neumann holds a patent for a "Reporter gene construct for the detection of HIV Rev and HIV Tat." This invention relates to a reporter gene construct designed to detect the HIV Rev and HIV Tat proteins. The patent outlines a functionality test method for Rev and Rev fusion proteins prepared in a recombinant manner. It also includes methods for screening sequences of different origins for their activity as instability elements. Additionally, it describes a method for detecting HIV-infected cells. The reporter gene construct, once introduced into cells, leads to the formation of reporter proteins in the presence of HIV Rev and HIV Tat proteins, allowing for quantitative and qualitative detection.
Career Highlights
Markus Neumann is associated with the GSF-Forschungszentrum für Umwelt und Gesundheit GmbH, where he has contributed to various research initiatives. His work has been pivotal in advancing the understanding of HIV detection and the development of innovative solutions in the field.
Collaborations
Neumann has collaborated with esteemed colleagues such as Ruth Brack-Werner and Horst Wolff. These partnerships have enhanced the research efforts and broadened the impact of their findings in the scientific community.
Conclusion
Markus Neumann's innovative work in the detection of HIV proteins exemplifies the critical role of inventors in advancing medical research. His contributions continue to influence the field and provide valuable tools for addressing health challenges.